US EditionPublished • loading... • Updated
Gilead stock hits fresh 52-week high as Wall Street lifts targets into earnings
Summary by ts2.tech
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Gilead stock hits fresh 52-week high as Wall Street lifts targets into earnings
New York, Jan 27, 2026, 14:29 (EST) — Regular session Shares of Gilead Sciences climbed $2.46, or 1.8%, to $140.24 Tuesday afternoon, hitting a fresh 12-month peak at $141.69 earlier in the session. The stock’s steady climb is pulling momentum money back into big-cap biotech, as traders focus on research notes suggesting estimates are beatable and policy noise is calming down. This is key since Gilead heads into earnings season with expectations…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
